StemCyte International, Ltd. (TPEX:4178)
Taiwan
· Delayed Price · Currency is TWD 25.20
+0.20 (0.80%)
At close: Dec 4, 2025
StemCyte International Revenue
StemCyte International had revenue of 197.31M TWD in the half year ending June 30, 2025, with 10.24% growth. This brings the company's revenue in the last twelve months to 385.12M, up 3.76% year-over-year. In the year 2024, StemCyte International had annual revenue of 382.69M with 5.49% growth.
Revenue (ttm)
385.12M
Revenue Growth
+3.76%
P/S Ratio
13.13
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.06B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Taiwan Semiconductor Manufacturing Company | 3,631.43B |
| Hon Hai Precision Industry | 7,627.24B |
| Delta Electronics | 507.47B |
| MediaTek | 583.82B |
| Fubon Financial Holding | 908.81B |
| Quanta Computer | 1,902.36B |
| Chunghwa Telecom | 235.76B |
| ASE Technology Holding | 629.74B |